Isabelle Treilleux has not added Biography.
If you are Isabelle Treilleux and would like to personalize this page please email our Author Liaison for assistance.
Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2008 | Pubmed ID: 18353983
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.
Journal of molecular endocrinology Feb, 2009 | Pubmed ID: 18984771
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis.
Oncoimmunology May, 2012 | Pubmed ID: 22737622
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
Cancer research Oct, 2012 | Pubmed ID: 22836755
Activation of rapid oestrogen signalling in aggressive human breast cancers.
EMBO molecular medicine Nov, 2012 | Pubmed ID: 23065768
Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.
International journal of cancer Aug, 2013 | Pubmed ID: 23389942
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.
Cancer research Aug, 2013 | Pubmed ID: 23722543
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
Gynecologic oncology Jan, 2014 | Pubmed ID: 24157616
Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death.
EMBO molecular medicine Dec, 2013 | Pubmed ID: 24293316
LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
International journal of cancer Sep, 2014 | Pubmed ID: 24615515
Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution.
American journal of surgery Aug, 2014 | Pubmed ID: 24680949
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.
Carcinogenesis May, 2015 | Pubmed ID: 25823895
Role of JMJD6 in Breast Tumourigenesis.
PloS one , 2015 | Pubmed ID: 25951181
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Histopathology Jan, 2016 | Pubmed ID: 26033501
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
BMC cancer Jun, 2015 | Pubmed ID: 26040677
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.
Nature communications 07, 2016 | Pubmed ID: 27406316
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.
Oncotarget Apr, 2017 | Pubmed ID: 28423606
Non-canonical NOTCH3 signalling limits tumour angiogenesis.
Nature communications 07, 2017 | Pubmed ID: 28719575
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS-driven Pancreatic Tumorigenesis.
Cellular and molecular gastroenterology and hepatology Sep, 2017 | Pubmed ID: 28752115
Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.
Scientific reports May, 2018 | Pubmed ID: 29743633
Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.
International journal of molecular sciences Jun, 2019 | Pubmed ID: 31195751
Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.
Cells 04, 2020 | Pubmed ID: 32290274
ERα-36 regulates progesterone receptor activity in breast cancer.
Breast cancer research : BCR 05, 2020 | Pubmed ID: 32429997
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.
European journal of cancer (Oxford, England : 1990) 03, 2021 | Pubmed ID: 33578357
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Breast cancer research : BCR 05, 2021 | Pubmed ID: 34020697
A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction.
Journal of inflammation research , 2021 | Pubmed ID: 34045885
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.
Breast cancer research and treatment Dec, 2021 | Pubmed ID: 34561764
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
Cancers Feb, 2022 | Pubmed ID: 35267497
Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma.
International journal of environmental research and public health 04, 2022 | Pubmed ID: 35564776
NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.
Aging cell Jul, 2022 | Pubmed ID: 35653631
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
Neurology(R) neuroimmunology & neuroinflammation Sep, 2022 | Pubmed ID: 35821104
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten